Tarlatamab
Drug timelines are a Plus or Pro feature.
31 regulatory and trial events tracked for Tarlatamab, covering 2025-02-10 to 2026-04-29. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) [Phase 3]